ARTICLE | Company News
Cel-Sci and NCI collaborate
June 15, 2000 7:00 AM UTC
Cel-Sci (CVM; Berlin:LSR) entered into a CRADA with the NCI to develop vaccines to treat or prevent HIV using NCI's HIV peptide epitopes and CVM's Ligand Epitope Antigen Presentation System ( L.E.A.P....